CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46 TWD | -0.65% |
|
+2.45% | -19.86% |
Chart calendar Chunghwa Chemical Synthesis & Biotech Co., Ltd.
f00cddcd9ee709661bfac8f9a0.mS61bHsPsrFPQyahITnOoGTR0aHDJ0xG0wLjmtC1x-g.-mzqFBFE19AVBEfJcw2c_wi6uZPzZQItinjU2brGt5_AYf8zLVbh6B1xcw~5509fd34b057ad30790432615e2b1e61
Upcoming events on Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Past events on Chunghwa Chemical Synthesis & Biotech Co., Ltd.
| 10/04/2024 07:22 | March 2024 Sales and Revenue Release |
| 28/03/2024 05:56 | Q4 2023 Earnings Release |
| 26/03/2024 06:00 | Fubon Securities Investor Conference |
| 08/03/2024 09:36 | February 2024 Sales and Revenue Release |
| 07/02/2024 08:08 | January 2024 Sales and Revenue Release |
| 10/01/2024 06:09 | December 2023 Sales and Revenue Release |
| 12/11/2023 | Q3 2023 Earnings Release |
| 09/11/2023 | October 2023 Sales and Revenue Release |
| 06/10/2023 10:17 | September 2023 Sales and Revenue Release |
| 08/09/2023 10:39 | August 2023 Sales and Revenue Release |
| 11/08/2023 06:27 | Q2 2023 Earnings Release |
| 10/08/2023 08:18 | July 2023 Sales and Revenue Release |
| 09/07/2023 | June 2023 Sales and Revenue Release |
| 08/06/2023 | May 2023 Sales and Revenue Release |
| 30/05/2023 02:00 | Annual General Meeting |
| 09/05/2023 | April 2023 Sales and Revenue Release |
| 31/03/2023 06:32 | Q4 2022 Earnings Release |
| 29/03/2023 07:00 | Fubon Securities Investor Conference |
| 25/08/2022 07:00 | Investor Meeting - Yuanta Securities |
| 08/08/2022 | Interim 2022 Earnings Release |
Past dividends on Chunghwa Chemical Synthesis & Biotech Co., Ltd.
| 23/07/2023 | Annual 1.3 TWD |
| 21/07/2022 | Annual 1.3 TWD |
| 21/07/2021 | Annual 1.5 TWD |
| 22/07/2020 | Annual 0.8 TWD |
| 23/07/2019 | Annual 1.2 TWD |
| 23/07/2018 | Annual 0.5 TWD |
| 23/07/2017 | Annual 0.5 TWD |
| 21/07/2016 | Annual 1.5 TWD |
| 22/07/2015 | Annual 0.5 TWD |
| 27/07/2014 | Annual 1 TWD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,00 0,00 - | 1 544 1 419 8.78% | 1 935 1 990 -2.78% | 2 117 2 117 0.01% | 2 086 2 592 -19.5% | 1 730 |
|
EBITDA Million TWD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 570 701 -18.56% | 758 702 7.91% | 0,00 0,00 - | 0,00 |
|
EBIT Million TWD | Released Forecast Spread | 0,00 0,00 - | 269 259 3.83% | 438 495 -11.33% | 464 464 -0.1% | 281 348 -19.31% | 219 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 0,00 0,00 - | 650 627 3.72% | 498 535 -6.99% | 583 583 0.05% | 333 419 -20.41% | 259 |
|
Net income Million TWD | Released Forecast Spread | 0,00 0,00 - | 532 517 2.88% | 401 423 -5.14% | 466 466 -0.03% | 265 327 -18.99% | 207 |
|
EPS TWD | Released Forecast Spread | 1,50 1,50 0% | 6,79 6,66 1.95% | 5,17 5,45 -5.05% | 6,01 6,00 0.17% | 3,39 4,22 -19.67% | 2,68 |
| Announcement Date | 30/03/20 | 30/03/21 | 31/03/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 508 563 -9.83% | 530 420 26.08% | 579 558 3.84% | 466 530 -12.04% | 542 542 0.09% | 765 738 3.79% | 526 526 0.08% | 339 600 -43.49% | 455 700 -34.93% | 280 | 400 | 400 | 650 |
|
EBITDA Million TWD | Released Forecast Spread | 113 309 -63.49% | 188 231 -18.79% | 186 241 -22.73% | 130 311 -58.12% | |||||||||
|
EBIT Million TWD | Released Forecast Spread | 77,1 133 -41.82% | 147 97,0 51.36% | 145 145 0.47% | 88,2 117 -24.6% | 83,1 83,0 0.07% | 206 206 0.13% | 30,3 115 -73.68% | -8,53 42,0 -120.31% | 53,3 70,0 -23.85% | 5,00 | 54,0 | 54,0 | 107 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 99,9 138 -27.33% | 167 97,0 71.92% | 196 148 32.7% | 143 123 16.52% | 77,7 78,0 -0.34% | 224 220 1.84% | 47,8 113 -57.68% | 12,4 60,0 -79.33% | 49,7 88,0 -43.51% | 15,0 | 64,0 | 64,0 | 117 |
|
Net income Million TWD | Released Forecast Spread | 91,3 113 -18.87% | 128 79,0 61.6% | 148 121 22.48% | 121 92,5 30.49% | 69,6 70,0 -0.56% | 179 176 2.13% | 29,6 89,0 -66.74% | 11,8 48,0 -75.35% | 44,2 70,0 -36.82% | 12,0 | 51,0 | 51,0 | 93,0 |
|
EPS TWD | Released Forecast Spread | 1,18 1,46 -18.9% | 1,63 1,02 59.8% | 1,90 1,56 21.99% | 1,54 1,19 29.41% | 0,90 0,90 0% | 2,31 2,26 2.21% | 0,38 1,14 -66.67% | 0,15 0,62 -75.81% | 0,57 0,91 -37.36% | 0,15 | 0,66 | 0,66 | 1,20 |
| Announcement Date | 31/03/22 | 13/05/22 | 12/08/22 | 11/11/22 | 31/03/23 | 15/05/23 | 11/08/23 | 13/11/23 | 28/03/24 | - | - | - | - |
| 06/05/2024 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
| 07/05/2024 12:30 | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 08/05/2024 12:55 | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for Chunghwa Chemical Synthesis & Biotech Co., Ltd.
| 02/05/2024 21:05 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 12:50 | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 30/04/2024 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 29/04/2024 22:53 | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 28/04/2024 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1762 Stock
- Calendar Chunghwa Chemical Synthesis & Biotech Co., Ltd.
